• Our Offering
    • small molecules

      • Preclinical Services
      • IND/Clinical Supply
      • Drug Substance
      • API
      • Advanced Intermediate
      • Highly Potent API
      • ADC Payload
      • Drug Product
      • Particle Engineering
      • Bioavailability Enhancement
      • Oral Solid
      • Inhalation
      • Parenteral
    • biologics

      • Preclinical Offering
      • Expression Technologies
      • Discovery Services
      • Drug Substance
      • Mammalian
      • Microbial
      • ADCs / Bioconjugates
      • Ibex® Solutions
      • Drug Product
      • Parenteral
    • cell & gene

      • Allogeneic Cell Therapy
      • iPSC Manufacturing
      • Exosomes
      • Cell Based Immunotherapies
      • Autologous Cell Therapy
      • Cell Based Immunotherapies
      • Viral Vectors
      • Services
      • Process Development
      • cGMP Manufacturing
      • Regulatory Support
      • Tissue Acquisition
      • Products
      • Cocoon® Platform
    • bioscience

      • Primary & Stem Cells
      • Bioprocessing Media
      • CellBio Services
      • Culture Media & Reagents
      • ADME & Toxicology
      • Transfection
      • Cell Assays & Analysis
      • Electrophoresis
      • Informatics – Paperless Solutions
      • QC & Endotoxin Detection
      • Automated Sterile Sampling
    • capsules

      • Immediate Release
      • Modified Release
      • Vegetarian
      • Inhalation
      • Over the Counter (OTC)
      • IND / Clinical Supply
      • Equipment
  • Resources
      • technologies & products

        We develop proprietary technology and licensing partnerships to ensure you have access to best-in-class solutions that add value to your own science.

      • regulatory support

        In close collaboration with you, Lonza Regulatory Affairs provide a CMC dossier suitable to the stage of clinical development of your product manufactured by Lonza.

      • technical support

        The collective expertise of our multi-disciplinary team in protein expression and production processes can help you get the most from our industry-leading technologies.

      • knowledge center

        Gather additional industry and technical information from our repository of resources and educational content.

  • About Us
    • about us

      Delivering the medicines of tomorrow today

    • careers

      Find opportunities

    • events

      the next conversation...

    • locations

      View our locations

    • news

      View press releases

  • Contact Us
Our Offering
small molecules
  • Preclinical Services
  • IND/Clinical Supply
  • Drug Substance
  • API
  • Advanced Intermediate
  • Highly Potent API
  • ADC Payload
  • Drug Product
  • Particle Engineering
  • Bioavailability Enhancement
  • Oral Solid
  • Inhalation
  • Parenteral
biologics
  • Preclinical Offering
  • Expression Technologies
  • Discovery Services
  • Drug Substance
  • Mammalian
  • Microbial
  • ADCs / Bioconjugates
  • Ibex® Solutions
  • Drug Product
  • Parenteral
cell & gene
  • Allogeneic Cell Therapy
  • iPSC Manufacturing
  • Exosomes
  • Cell Based Immunotherapies
  • Autologous Cell Therapy
  • Cell Based Immunotherapies
  • Viral Vectors
  • Services
  • Process Development
  • cGMP Manufacturing
  • Regulatory Support
  • Tissue Acquisition
  • Products
  • Cocoon® Platform
bioscience
  • Primary & Stem Cells
  • Bioprocessing Media
  • CellBio Services
  • Culture Media & Reagents
  • ADME & Toxicology
  • Transfection
  • Cell Assays & Analysis
  • Electrophoresis
  • Informatics – Paperless Solutions
  • QC & Endotoxin Detection
  • Automated Sterile Sampling
capsules
  • Immediate Release
  • Modified Release
  • Vegetarian
  • Inhalation
  • Over the Counter (OTC)
  • IND / Clinical Supply
  • Equipment
Resources
technologies & products
regulatory support
technical support
knowledge center
About Us
about us
careers
events
locations
news
Contact Us

Our latest news and announcements

    • Knowledge Center
    • Offerings
    • About Us
    • Technologies & Products
    • Contact us
  • About Us
    • Locations
    • Job search
    • Events
  • News
Filter by News Category
Partnerships (3) General (2) New Products (2)
Filter by Market
Pharma and Biotech (6) Corporate (2)
Filter by Year
2014 (6)
Filter by Language
English (6)
2014X
EnglishX
Showing 1‐6 of 6
results per page
10 Dec 2014
Lonza Executes Collaboration Agreements with Two Innovation Clusters
Lonza Executes Collaboration Agreements with Two Innovation Clusters
03 Nov 2014
Lonza and Celladon Corporation Establish a Strategic Commercial Manufacturing Collaboration for MYDICAR®
Lonza and Celladon Corporation Establish a Strategic Commercial Manufacturing Collaboration for MYDICAR®
30 Oct 2014
Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement
Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement
04 Sep 2014
Lonza Introduces Services for Rational Vaccine Design and Development to Help Reduce the Cost of Failure and Increase the Chance of Clinical Success
Lonza Introduces Services for Rational Vaccine Design and Development to Help Reduce the Cost of Failure and Increase the Chance of Clinical Success
17 Apr 2014
Lonza’s Facility in Singapore Received Good Manufacturing Practice (GMP) Certification from the HSA
Lonza’s Facility in Singapore Received Good Manufacturing Practice (GMP) Certification from the HSA
13 Jan 2014
Lonza Extends Partnership with Pharmacyclics to Support Manufacturing of Recently Approved Oncology Therapeutic, IMBRUVICA™
Lonza Extends Partnership with Pharmacyclics to Support Manufacturing of Recently Approved Oncology Therapeutic, IMBRUVICA™
About Us
  • Careers
  • Events
  • Locations
  • News
Resources
  • Knowledge Center
  • Technologies and Products
  • Technical Support
  • Regulatory Support
Terms
  • Legal Disclaimer
  • Privacy Policy
  • Sitemap
www.lonza.com
© 2021 Lonza. All Rights Reserved.
By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy and Cookie policies.